Gate Bioscience
PrivateLast Round
Series B
Nov 13, 2025
Est. Valuation
$161M
Total Funding Raised
$135M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Gate Bioscience operates in Healthcare & Life Sciences and is based in Brisbane, California. Its latest recorded funding round was a Series B round in November 2025.
Gate Bioscience is a biotechnology company that develops small molecule drugs known as Molecular Gates to selectively eliminate disease-causing extracellular proteins at their source within cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Gate Bioscience Comparables
Compare Gate Bioscience with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Magnet Biomedicine | 81% | |
| Plexium | 80% | |
| Proxygen | 78% |
For institutional investors. Book with your work email.
Gate Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Nov 13, 2025 | ||||
| Series A | Nov 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Gate Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Andreessen Horowitz | Seed, Series B, Series A |
| GV | Series A, Series B |
| Forbion | Series B |
| ARCH Venture Partners | Series A, Series B |
| Versant Ventures | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 36% MoM, reaching 2.3K.
- Jul 25, 2026
Monthly visitors increased 36% MoM to 1.7K.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 6, 2026
GateBioscience, Inc. partners with Lilly International to expand their multi-year collaboration and license agreement to discover, develop, and commercialize molecular gate therapeutics, adding one target and an option for a second in California on Oct 5th '26.
- is_developingOct 5, 2026
GateBioscience, Inc. is developing oral medicines that eliminate disease-causing proteins with Eli Lilly under an expanded partnership announced on Oct 6th '26, adding one target and an option to select a second.
For institutional investors. Book with your work email.
Gate Bioscience Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Gate Bioscience's valuation, stock price, and market status.
Is Gate Bioscience a public or private company?
Gate Bioscience is a private company.
What is the current stock price of Gate Bioscience?
Gate Bioscience is a private company, so its shares have no public market price. Caplight tracks Gate Bioscience's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Gate Bioscience worth (valuation)?
Gate Bioscience's valuation is estimated at $161.0M based on funding round data.
Can I buy Gate Bioscience stock?
Gate Bioscience shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Gate Bioscience's last funding round?
Gate Bioscience's most recent funding round was Series B on November 13, 2025.
Who are the main investors in Gate Bioscience?
Key investors in Gate Bioscience include Andreessen Horowitz, Forbion, Versant Ventures.
Will Gate Bioscience IPO soon?
No public IPO plans have been announced for Gate Bioscience.
How can I track Gate Bioscience secondary market activity?
Caplight tracks bids, offers, and trades in Gate Bioscience's shares on secondary markets.